What is VINC's earnings growth forecast for 2025-2025?
(NASDAQ: VINC) Vincerx Pharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.2%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.12%.
Vincerx Pharma's earnings in 2025 is -$30,074,000.
In 2025, VINC is forecast to generate -$33,499,373 in earnings, with the lowest earnings forecast at -$33,499,373 and the highest earnings forecast at -$33,499,373.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.